| ZBRA |
Report |
Non-GAAP EPS (Q2 2026) |
BEAT |
pred ~$4.55 vs. cons $4.37 |
MEDIUM |
| ZBRA |
Report |
Revenue (Q2 2026) |
IN-LINE |
pred ~$1.505B vs. cons $1.499B |
MEDIUM |
| ZBRA |
Report |
Adj. Gross Margin (Q2 2026) |
IN-LINE |
pred ~48.5% vs. cons 48.2% |
MEDIUM |
| ZBRA |
Guide |
FY 2026 Non-GAAP EPS (FY 2026) |
BETTER |
guide mid ~$18.70 vs. cons $18.58 |
MEDIUM |
| ZBRA |
Guide |
FY 2026 Revenue (FY 2026) |
UNCHANGED |
guide reaffirm 10-14% (mid ~$6.04B) vs. cons $6.07B |
HIGH |
| ZBRA |
Guide |
FY 2026 Adj. EBITDA Margin (FY 2026) |
UNCHANGED |
guide reaffirm ~22% vs. cons ~22.2% |
HIGH |
| ZBRA |
Guide |
Q3 2026 Revenue (Q3 2026) |
UNCHANGED |
guide mid ~$1.545B vs. cons ~$1.55B |
MEDIUM |
| ZBRA |
Return |
Day-1 residual (stock − beta × S&P 500) |
+3.0% |
— |
MEDIUM |
| ZBRA |
Return |
5-day cumulative residual |
+1.0% (FADE) |
FADE — H2 implied EPS math is flat-to-slightly-below consensus; initial pop partially given back as sell-side digests out-period math; no follow-through catalyst absent a memory supply upgrade signal |
MEDIUM |